IGM Biosciences, Inc.
MULTIMERIC CD40 BINDING MOLECULES AND USES THEREOF
Last updated:
Abstract:
This disclosure provides dimeric, pentameric, and hexameric CD40 agonist binding molecules and methods of using such binding molecules to induce anti-tumor immunity.
Status:
Application
Type:
Utility
Filling date:
17 Dec 2021
Issue date:
7 Apr 2022